-(10H-phenothiazin-10-yl)propyl]-2-(substituted phenyl)-4-oxo-3-thiazolidinecarboxamide, 4a-s. The latter product on treatment with several selected substituted aromatic aldehydes in the presence of C 2 H 5 ONa underwent the Knoevenagel reaction to yield 5a-s. The structure of compounds 1, 2, 3a-s, 4a-s and 5a-s were confirmed by IR, 1 H-NMR, 13 C-NMR and FAB mass spectroscopy and by chemical analysis. All the above compounds were screened for their antimicrobial activity against some selected bacteria and fungi and for their antituberculosis activity, the compounds were screened against the bacterium Mycobacterium tuberculosis.
INTRODUCTION
Thiazolidines have been shown to possess various remarkable biological activities such as analgesic, 1 amoebicidal, 2 nematocidal, 3 anaesthetic, 4 mosquito--repеllent, 5 anti-HIV, anticancer, 6 antibacterial, [7] [8] [9] [10] [11] [12] antifungal, [13] [14] antiinflammatory, [16] [17] [18] [19] antitubercular, [20] [21] [22] EGFR and HER-2 kinase inhibitor, 23 antiproliferative, 24, 25 etc. Phenothiazine is also a bioactive heterocyclic compound of pharmaceutical importance and possesses different biological activities viz. antibacterial, 26, 27 antifungal, 28 antitubercular, 29 and anti-inflammatory. 30 In the present study, compounds 1, 2, 3a-s, 4a-s and 5a-s were synthesized as shown in Scheme 1. The starting material, phenothiazine with 1-bromo-3-chloropropane un-18 SHARMA et al. derwent an nucleophilic substitution reaction yielding 10-(3-chloropropyl)-10H-phenothiazine, compound 1. Compound 1 on reaction with urea afforded N- [3- (10H-phenothiazin-10-yl)propyl]urea, compound 2. Compound 2 on reaction with several selected substituted benzaldehydes underwent a condensation reaction to afford N- [3-(10H-phenothiazin-10-yl) propyl]-N'-[(substituted phenyl)-methylidene]urea, compounds 3a-s. The reaction of thioglycolic acid with compounds 3a-s in the presence of anhydrous ZnCl 2 gave new heterocyclic compounds N- [3-(10H-phenothiazin-10-yl) propyl]-2-(substituted phenyl)-4-oxo-3--thiazolidinecarboxamide, compounds 4a-s. Compounds 4a-s on treatment with various selected substituted benzaldehydes in the presence of C 2 H 5 ONa underwent a Knoevenagel condensation reaction to yield the final products N-[3-(10H--phenothiazin-10-yl)propyl]-2-(substituted phenyl)-4-oxo-5-(substituted benzylidene)-3-thiazolidine-carboxamide, compounds 5a-s. The structures of all the newly synthesized compounds 1, 2, 3a-s, 4a-s and 5a-s were confirmed by IR, 1 H-NMR, 13 
EXPERIMENTAL
Melting points were taken in open capillaries and are uncorrected. The progress of the reactions was monitored on silica gel-G coated TLC plates using MeOH : CHCl 3 (1:9). The spot was visualized by exposing the dry plate to iodine vapour. The IR spectra were recorded in KBr discs on a Shimadzu 8201 PC FTIR spectrophotometer (ν max in cm -1 ) and the 1 H-and 13 C-NMR spectra were measured on a Bruker DRX-300 spectrometer in CDCl 3 at 300 and 75 MHz, respectively, using TMS as an internal standard. All chemical shifts are reported on δ scales. The FAB mass spectra were recorded on a Jeol SX-102 mass spectrometer. Elemental analyses were realised on a Carlo Erba-1108 analyzer. The analytical data of all the compounds were highly satisfactory. For column chromatographic purification of the products, Merck silica Gel 60 (230-400 Mesh) was used. The employed reagent grade chemicals were purchased from commercial sources and further purified before use.
Synthesis of 10-(3-chloropropyl)-10H-phenothiazine, compound 1
Phenothiazine (0.301 mol) and 1-bromo-3-chloropropane (0.301 mol) in ethanol (100 ml) were stirred on a magnetic stirrer for 5.0 h at room temperature. Completion of the reaction was monitored on silica gel-G coated TLC plates. The product was filtered and purified over a silica gel packed column chromatography using CHCl 3 :CH 3 OH (8:2 v/v) as the eluant (120 ml). The purified product was dried under vacuum and recrystallized from acetone to yield compound 1 (Fig. 1 ). 
Synthesis of N-[3-(10H-phenothiazin-10-yl)propyl]urea, compound 2
Compound 1 (0.20 mol) and urea (0.20 mol) in ethanol (100 ml) were stirred on a magnetic stirrer for 4.0 h at room temperature. The completion of the reaction was monitored by silica gel-G coated TLC plates. The product was filtered and purified over a silica gel packed column chromatography using CHCl 3 :CH 3 OH (8:2 v/v) as eluant (120 ml). The purified product was dried under vacuo and recrystallized from ethanol to yield compound 2 ( 
Synthesis of
Compound 2 (0.026 mol) and benzaldehyde (0.026 mol) in ethanol (100 ml) in the presence of 2-4 drops glacial acetic acid were first stirred on a magnetic stirrer for 2.0 h at room temperature followed by refluxing on a steam bath at 80-90 °C for 3.3 h. The completion of the reaction was monitored using silica gel-G coated TLC plates. The product was filtered, cooled and purified over a silica gel packed column chromatography using CH 3 OH:CHCl 3 (7:3 v/v) as eluant (90 ml). The purified product was dried under vacuum and recrystallized from acetone at room temperature to furnish compound 3a (Fig. 3) .
Compounds 3b-s (Fig. 3) were synthesized using a similar method. 
3(a-s)

Synthesis of 4-oxo-N-[3-(10H-phenothiazin-10-yl)propyl]-2-(phenyl)-3-thiazolidine-carboxamide, compound 4a
Compound 3a (0.0129 mol) and thioglycolic acid (0.0129 mol) in methanol (50 ml) in the presence of ZnCl 2 were first stirred on a magnetic stirrer for 2.0 h at room temperature followed by refluxing on a steam bath at 70-90 °C for 6.0 h. The completion of the reaction was monitored using silica gel-G coated TLC plates. The product was filtered, cooled and purified over a silica gel packed column chromatography using CH 3 OH:CHCl 3 (7:3 v/v) as eluant (80 ml). The purified product was dried under vacuum and recrystallized from ethanol at room temperature to furnish compound 4a (Fig. 4) .
Compounds 4b-s (Fig. 4) were synthesized using a similar method. Compound 4a (0.008 mol) and benzaldehyde (0.008 mol) in ethanol (50 ml) in the presence of CH 3 CH 2 ONa were first stirred on a magnetic stirrer for 2.0 h at room temperature followed by refluxing on a steam bath at 80-90 °C for 5.0 h. Completion of the reaction was monitored using silica gel-G coated TLC plates. The product was filtered, cooled and purified by a silica gel packed column chromatography using CH 3 OH:CHCl 3 (7:3 v/v) as eluant (70 ml). The purified product was dried under vacuum and recrystallized from ethanol at room temperature to furnish compound 5a.
Compounds 5b-s were synthesized using a similar method.
Biological study
The antibacterial, antifungal and antitubercular activities of compounds 1, 2, 3a-s, 4a-s and 5a-s were assayed in vitro against selected bacteria, i.e., Escherichia coli, Bacillus subtilis, Staphylococus aureus, and selected fungi, Aspergillus flavus, Aspergillus niger and Candida albicans H37Rv strain. The inhibition zone (mm) of compounds 1, 2, 3a-s, 4a-s and 5a-s were determined using the filter paper disc diffusion method 31 (antibacterial and antifungal activity) at two concentration of 50 and 100 ppm and the percentage activity of compounds 1, 2, 3a-s, 4a-s and 5a-s were determined using the L. J. medium (conventional) method (antitubercular activity) at 25 and 50 μg mL -1 and lower concentrations. Streptomycin and griseofulvin were used as the standard for the antibacterial and antifungal activity, respectively, and for the antitubercular activity, isoniazid and rifampicin were taken as standards.
RESULTS AND DISCUSSION
The analytical and spectral data of the synthesized compounds are given in the Supplementary material to this paper.
The reaction of 1-bromo-3-chloropropane with phenothiazine was performed in ethanol as solvent to afford compound 1. The spectroscopic analyses of compound 1 showed absorption peaks for N-CH, C-Cl and C-S-C at 1272, 774 and 687 cm -1 in the IR spectrum. The IR spectrum confirms the formation of compound 1. This fact was also supported by the disappearance of NH absorption of the phenothiazine.
Compound 1 on reaction with urea under continuous stirring at room temperature yielded compound 2. In the spectroscopic analyses of compound 2, three absorption peaks were found in the IR spectrum for NH, NH 2 and CO at 3342, 3412 and 1655 cm -1 , respectively while the absorption of C-Cl found in the spectrum of 1 had disappeared. This clearly indicated that compound 1 underwent substitution reaction with urea. This fact was also supported by the 1 H-and 13 C-NMR spectra as two signals appeared in the 1 H-NMR spectrum for NH and NH 2 at δ 5.83 and 5.99 ppm, respectively. The formation of compound 2 was fully supported by the signal for the CO group at δ 163.4 ppm in the 13 C-NMR spectrum. All the facts together were strong evidence for the synthesis of compound 2.
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Substituted benzaldehydes underwent condensation reaction with compound 2, resulting in the formation of Schiff bases N=CH, which was confirmed by the IR, 1 H-NMR and 13 C-NMR spectra of compounds 3a-s. In the IR spectra, an absorption was found in the range 1531-1584 cm -1 , while a strong signal appeared in the range of δ 7.84-8.34 and 143-158.4 ppm in the 1 H-NMR and 13 C-NMR spectra of compounds 3a-s, respectively. These facts were also supported by the disappearance of the signal for NH 2 present in the 1 H-NMR spectrum of compound 2.
Compounds 3a-s on reaction with an equimolar amount of thioglycolic acid in the presence of ZnCl 2 underwent a reaction whereby a five-membered thiazolidinone ring was formed, compounds 4a-s. Compounds 4a-s showed a characteristic absorption for a cyclic carbonyl group in the range 1725-1758 cm -1 in the IR spectra. The 1 H-NMR spectra of compounds 4a-s clearly indicated the presence of the active methylene group in the thiazolidine ring by exhibiting a signal in the range δ 3.26-3.68 ppm. The 13 C-NMR spectra of compounds 4a-s also supported the fact that a cyclic carbonyl group was present by the signal that appeared in the range δ 160.4-178.8 ppm. These facts were supported by a) the disappearance of the N=CH proton and b) the appearance of a N-CH proton in the range of δ 5.23-5.82 ppm in the 1 H-NMR spectra of compounds 4a-s.
Compounds 4a-s underwent a Knoevenagel condensation reaction with substituted benzaldehydes in the presence of alkali metal alkoxide (C 2 H 5 ONa) to afford compounds 5a-s. In the 1 H-NMR spectra of compounds 5a-s, the two methylene protons of compounds 4a-s were absent and a new signal for C=CH appeared in the range δ 6.32-6.77 ppm and in the 13 C-NMR spectra of compounds 5a-s, two new signals for C=CH and C=CH appeared in the δ range 134.6-143.2 and 140.1-149.2 ppm, respectively. All these facts clearly confirmed the synthesis of all the final products.
Biological study
The results of the antimicrobial (antibacterial, antifungal and antitubercular) activities are summarized in Table I . All the compounds 1, 2, 3a-s, 4a-s and 5a-s were screened for their antimicrobial activity against selected strains of bacteria and fungi and antitubercular activity against M. tuberculosis (H37Rv strain). The investigation of antimicrobial data revealed that compounds 5c, 5d, 5e, 5f, 5h, 5i and 5j displayed high activity, compounds 4h, 4j, 5b, 5g and 5q showed moderate activity and the other compounds showed less activity against all the strains compared with standard drugs.
The compounds exhibited a structure-activity relationship (SAR) because the activity of compounds varies with substitution. The nitro group-containing compounds 5h, 5i and 5j showed higher activity than the chloro group-(5c and 5d) or the bromo group-containing compounds (5e and 5f). In addition, the SYNTHESIS AND BIOLOGICAL ACTIVITY OF 4-THIAZOLIDINONE DERIVATIVES OF PHENOTHIAZINE 23 chloro-and bromo-derivatives also had a higher activity than the other tested compounds. Based on the SAR, it could be concluded that the activity of compounds depended on the electron withdrawing nature of the substituent groups. The sequence of the activity is following: NO 2 > Cl > Br > OCH 3 < OH > CH 3 
CONCLUSIONS
The present research study reports the successful synthesis of all the newly synthesized compounds 1, 2, 3a-s, 4a-s and 5a-s. Some of the synthesized compounds displayed good biological activities while the others showed lower antimicrobial and antitubercular activities.
